AVITA Medical, Inc. Stock Other OTC
Equities
AVHHL
AU000000AVH4
Biotechnology & Medical Research
Sales 2024 * | 113M 74.71M | Sales 2025 * | 158M 104M | Capitalization | 360M 237M |
---|---|---|---|---|---|
Net income 2024 * | -66M -43.51M | Net income 2025 * | -32M -21.1M | EV / Sales 2024 * | 2.86 x |
Net cash position 2024 * | 36.16M 23.84M | Net Debt 2025 * | 2.27M 1.49M | EV / Sales 2025 * | 2.3 x |
P/E ratio 2024 * |
-5.29
x | P/E ratio 2025 * |
-11.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.29% |
Latest transcript on AVITA Medical, Inc.
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.53% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |